Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance ("USOPTIVAL")

NCT04792684 is registered in ClinicalTrials.gov with Universal Diagnostics as lead sponsor.

NCT NCT04792684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04792684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance ("USOPTIVAL")
Lead sponsor
Universal Diagnostics
Phase
Observational
Overall status
Recruiting
Start date
December 30, 2020
Completion date
December 30, 2025
Enrollment
1,300 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

advanced adenomas (aa), colorectal cancer (crc)